CASI Pharmaceuticals Secures New Capital to Advance Key Medical Research

Rockville, Friday, 14 August 2026.
CASI Pharmaceuticals reported $9.8 million in first-half revenue while securing $15 million in new funding and a major legal victory to advance its lead drug trials.